COMMUNIQUÉS West-GlobeNewswire

TRACON Pharmaceuticals to Present at the 17th Annual Needham Healthcare Conference

21/03/2018 - 21:05

SAN DIEGO, March 21, 2018 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON ), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer [...]

Tonix Pharmaceuticals Expands Intellectual Property Portfolio for TNX-102 SL

21/03/2018 - 21:05

U.S. Patent Issued Covering the Use of Tonmya® (Cyclobenzaprine HCl Sublingual Tablets) for treating Posttraumatic Stress Disorder (PTSD) Patent Will Provide Intellectual Property Protection until at least 2030 for Use [...]

Aeterna Zentaris to Announce Fourth Quarter and Year End 2017 Financial and Operating Results on March 28th, 2018

21/03/2018 - 21:05

CHARLESTON, S.C., March 21, 2018 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS ) (TSX: AEZS ) will announce its fourth quarter and year ended December 31, 2017 financial and operating results after market [...]

Mersana Therapeutics to Host Conference Call Announcing Fourth Quarter and Full Year 2017 Financial Results and Business Updates

21/03/2018 - 21:01

CAMBRIDGE, Mass., March 21, 2018 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN ), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates ( [...]

Mersana Therapeutics to Host Conference Call Announcing Fourth Quarter and Full Year 2017 Financial Results and Business Updates

21/03/2018 - 21:01

CAMBRIDGE, Mass., March 21, 2018 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN ), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates ( [...]

Solon Eiendom ASA : Primary insider notification

21/03/2018 - 15:35

(Oslo, Norway, 21 March 2018) Per Knut Asphaug Bernhardt, personal assistant to the chairman of the board of Solon Eiendom ASA, (through his wholly owned company Factum AS) has today rolled over a forward contract for [...]

Sport Endurance Wholly-Owned Subsidiary, Yield Endurance, Enters into Strategic Partnership with Madison Partners

21/03/2018 - 14:47

JERSEY CITY, N.J., March 21, 2018 (GLOBE NEWSWIRE) -- Sport Endurance, Inc. (OTCQB:SENZ) (the “Company”) wholly-owned subsidiary, Yield Endurance, Inc., today announced entering into a strategic partnership and [...]

HealthLynked Corp. Announces Dr. Michael Dent, CEO is presenting at the NIBA New York Conference on March 27, 2018

21/03/2018 - 14:43

NAPLES, Fla., March 21, 2018 (GLOBE NEWSWIRE) -- HealthLynked Corp. (OTCQB:HLYK) today announced that Dr. Michael Dent, its Chief Executive Officer, is presenting at the National Investment Bankers Association (NIBA). [...]

FIT Biotech Oy: FIT Biotech Oy converts Convertible Capital Notes into shares and exceeds the authorization granted in the Extraordinary General Meeting on February 6, 2018

21/03/2018 - 14:30

FIT Biotech Oy Company release March 21, 2018 at 03:30 PM EET FIT Biotech Oy converts Convertible Capital Notes into shares and exceeds the authorization granted in the Extraordinary General Meeting on February 6, 2018 [...]

ProPhase Labs Reports Financial Results for the Year Ended December 31, 2017

21/03/2018 - 14:06

DOYLESTOWN, Pa., March 21, 2018 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH ), ( www.ProPhaseLabs.com ) today reported its net sales from continuing operations were $9.9 million for the year ended December 31 [...]

Immunicum AB: Invitation to Investor Events

21/03/2018 - 14:01

Press Release 21 March 2018 Immunicum AB: Invitation to Investor Events Immunicum AB (publ; IMMU.ST) a biopharmaceutical company advancing a novel, immune-priming cancer treatment against a variety of solid tumors, [...]

NewLink Genetics Appoints Chad A. Johnson to Board of Directors

21/03/2018 - 14:00

AMES, Iowa, March 21, 2018 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ: NLNK ) today announced the appointment of Chad A. Johnson, 39, to the Company's Board of Directors. In connection with this [...]

AXIM Biotech to Attend BioCentury’s 25th Annual Future Leaders in the Biotech Industry Conference in New York

21/03/2018 - 14:00

NEW YORK, March 21, 2018 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc . (AXIM ® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that George E. Anastassov, MD, DDS, MBA and [...]

Devonian Announces Grant of Options

21/03/2018 - 14:00

QUEBEC CITY, March 21, 2018 (GLOBE NEWSWIRE) -- Devonian Health Group Inc. (" Devonian " or the " Corporation ") (TSX VENTURE:GSD) announces that the Board of Directors has approved the grant of options (the ‘‘Options [...]

Devonian annonce l’octroi d’options

21/03/2018 - 14:00

QUÉBEC, 21 mars 2018 (GLOBE NEWSWIRE) -- Groupe Santé Devonian Inc. (« Devonian » ou la « Société ») (TSX CROISSANCE:GSD) annonce que le conseil d'administration a approuvé l'octroi d'options (les «options») pour [...]

Aquinox to Present at the 17th Annual Needham Healthcare Conference

21/03/2018 - 14:00

VANCOUVER, British Columbia, March 21, 2018 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“ Aquinox ”) (NASDAQ: AQXP ), a clinical-stage pharmaceutical company discovering and developing novel drug candidates to [...]

Scapa Healthcare Starts Construction on New Medical Device Manufacturing Facility in Knoxville, TN

21/03/2018 - 14:00

WINDSOR, Conn., March 21, 2018 (GLOBE NEWSWIRE) -- Scapa Healthcare , a trusted strategic outsource partner of skin-friendly, turnkey solutions for advanced wound care, medical device and consumer wellness markets, is [...]

SELLAS Life Sciences Announces Appointment of Barbara A. Wood as Executive Vice President, General Counsel and Corporate Secretary

21/03/2018 - 13:45

NEW YORK, March 21, 2018 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group Inc., (Nasdaq: SLS ) (SELLAS), a clinical-stage biopharmaceutical company focused on novel cancer immunotherapies for a broad range of cancer [...]

Allovate Therapeutics Announces Issuance of Second Japanese Patent, Expanding Global Coverage of the Oral Mucosal Immunotherapy Platform

21/03/2018 - 13:37

New York, March 21, 2018 (GLOBE NEWSWIRE) -- Allovate Therapeutics, a biopharmaceutical company focused on improving treatment options for allergies, announced today that the Japan Patent Office (JPO) has recently [...]